öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÀîÏòÑô
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º74

ËùÊôԺУ£ºÇຣ´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ£¨¸ßԭҽѧ·½Ïò£©
Ñо¿ÁìÓò£º ¸ßÔ­µÍÑõÓëÒ©Îï´úл
Ñо¿ÁìÓò£º ¸ßÔ­µÍÑõÓëÒ©Îï´úл [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÀú£º
1994.9-1998.7?? À¼ÖÝ´óѧҩѧԺ£¬Ò©Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñҽѧѧʿѧλ¡£

2000.9-2003.7?? ÖйúÒ©¿Æ´óѧ£¬Ò©Îï·ÖÎööλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñÀíѧ˶ʿѧλ¡£

2005.7-2006.6?? ÈÕ±¾Ðܱ¾´óѧҩѧ²¿£¬·ÃÎÊѧÕß¡£

2007.9-2010.7?? ÉòÑôÒ©¿Æ´óѧ£¬Ò©ÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬»ñÀíѧ²©Ê¿Ñ§Î»¡£

1998.9- 2012.5? Çຣ´óѧҽѧԺ´ÓʽÌѧºÍ¿ÆÑй¤×÷¡£

2012.5-???????? Çຣ´óѧÑо¿ÉúÔº
»ñ½±Çé¿ö£º
Ò»¡¢¿ÆÑгɹû£¨°´ÐòºÅ¡¢³É¹ûÏîÄ¿Ãû³Æ¡¢°ä·¢µ¥Î»¡¢»ñ½±µÈ¼¶¡¢±¾ÈËÅÅÃû¡¢»ñ½±Ê±¼ä·ÖÐÐÌîд£©

1.¸ßÔ­µÍÑõ¶Ô»Ç°·¼×‡fßòÒ©ÎﶯÁ¦Ñ§ÌØÕ÷µÄÓ°Ï죬Çຣʡ¿Æ¼¼½ø²½ÈýµÈ½±£¬2012Ä꣬µÚÈý



¿ÆÑй¤×÷ :
Ñо¿ÄÚÈݼò½é£º
ÔÚ¸ßÔ­¡°µÍÑõ¡¢µÍѹ¡¢µÍΡ¢Ç¿·øÉ䡱µÄÌØÊâ»·¾³ÖУ¬»úÌåµÄÌåÒº¡¢ÑªÒºÁ÷±äѧ¡¢ÑªÒºÉú»¯¡¢ÑªÆø¼°ÔàÆ÷¹¦Äܵȷ¢ÉúһϵÁÐÉúÀíÐԱ仯£¬²¿·Ö·¢Éú²¡ÀíÐԱ仯£¬ÕâЩ±ä»¯Ó°ÏìÒ©ÎïµÄÒ©´ú¶¯Á¦Ñ§ÌØÕ÷²¢¸Ä±äÒ©ÎïÔÚÌåÄÚµÄÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅй]¡£Ò©ÎïÔÚÌåÄÚ´úл¶¯Á¦Ñ§µÄ±ä»¯Ö±½ÓÓ°ÏìÒ©ÎïµÄÁÙ´²ÁÆЧºÍ°²È«ÐÔ£¬ÔÚ¸ßÔ­µØÇøÈçºÎºÏÀíÓÃÒ©Êܵ½Ñо¿ÕßµÄÆÕ±é¹Ø×¢¡£ÒÔÇà²Ø¸ßÔ­×ÔÈ»»·¾³ÎªÊµÑ鳡Ëù£¬Ì½ÌÖÁ˸ßÔ­µÍÑõ¶ÔÒ©Îï´úлµÄÓ°Ï죬Ϊ¸ßÔ­µØÇøÁÙ´²ºÏÀíÓÃÒ©ÌṩһЩÓмÛÖµµÄÒÀ¾Ý¡£
ÔÚÑпÆÑÐÏîÄ¿£º
1¡¢¸ßÔ­·ÅÁƶÔÑÎËáÒÁÁ¢Ì濵ҩ´ú¶¯Á¦Ñ§µÄÓ°Ïì¼°Æä»úÖÆÑо¿£¬Çຣʡ×ÔÈ»¿Æѧ»ù½ð£¬26ÍòÔª£¬2016.1-2017.12

2¡¢¸ßÔ­µÍÑõ¶ÔºËÊÜÌåPXRºÍCAR½éµ¼µÄCYP450ºÍUGT1A1ת¼µ÷½Ú×÷Ó㬹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬45ÍòÔª£¬2015.1-2018.12
ѧÊõÂÛÎÄ£º
Ò»¡¢±¾ÈË·¢±íÂÛÎÄ

1¡¢ÀîÏòÑô, Öì¿¡²©, ÀîÓÀƽ. ²ØÒ©×ôÌ«¶ÔCYP1A2ºÍNAT2»îÐÔ¼°µ°°×ºÍmRNA±í´ïµÄÓ°Ïì. ҩѧѧ±¨, 2014.

2¡¢ÀîÏòÑô, ÁõÓÀÄê, Ô¬Ã÷. ¸ßÔ­µÍÑõ¶ÔÒ©Îï´úлøCYP2C9ºÍ2C19»îÐÔ¼°µ°°×±í´ïµÄÓ°Ïì. ҩѧѧ±¨, 2012.

3¡¢ÀîÏòÑô, ÁõÓÀÄê, ÀîÓÀƽ. »Ç°·¼×‡fßòÔÚƽԭºº×å¡¢¸ßÔ­ÊÀ¾Óºº×åºÍ²Ø×彡¿µÈËÌåµÄÒ©Îï´úл¶¯Á¦Ñ§Ñо¿. ҩѧѧ±¨,2011.

4¡¢Li XY, Wang XJ, Li YP, et al. The activity, protein and mRNA expression of CYP2E1 and CYP 3A1 in rats after exposure to acute and chronic high-altitude hypoxia. High Alt Med Biol, 2014,

5¡¢Li XY, Wang XJ, Zhu JB, et al. Effect of exposure to acute and chronic high altitude hypoxia on the activity and expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 AND NAT2 in rats. Pharmacology, 2014.

¶þ¡¢Ñо¿Éú·¢±íÂÛÎÄ

1.Zhang JL, Zhu JB, Yao XC, et al. Pharmacokinetics of Lidocaine Hydrochloride Metabolized by CYP3A4 in Chinese Han Volunteers Living at Low Altitude and in Native Han and Tibetan Chinese Volunteers Living at High Altitude. Pharmacology, 2016.

2.Duan YB, Chen F, Yao XC, et al.Protective Effect of Lycium ruthenicum Murr. Against Radiation Injury in Mice.Int J Environ Res Public Health. 2015.

3.Ò¦Ðdz½£¬ÀîÏòÑô.êóÅ£µ°°×¶ÔXÉäÏßËðÉËСÊóµÄ·À»¤×÷ÓÃ. ÓªÑøѧ±¨£¬2015.

4.ÕžêÁá,ÀîÏòÑô,¸ßÔ­µÍÑõÓ°ÏìÒ©Îï´úлµÄÑо¿½øÕ¹.ҩѧѧ±¨£¬2015.

5.¶ÎÑűò£¬Ò¦Ðdz½£¬³ÂÏæºêµÈ.ºÚ¹ûèÛ轶ÔXÉäÏß·øÉäСÊóµÄ±£»¤×÷ÓÃÑо¿. ÌìÈ»²úÎïÑо¿Ó뿪·¢, 2015.

6.¶ÎÑűò£¬Ò¦Ðdz½£¬ÕžêÁáµÈ.ÖÐÒ©¿¹·øÉä×÷ÓÃÑо¿½øÕ¹.ҩѧÑо¿£¬2015.